News

Quotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility

Read Announcement

Search

9 results for "Tailored Services"

Turnkey solutions and individual services for drug development

Quotient Sciences Corporate Brochure 2022

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Our corporate brochure provides a key summary of who we are, what we represent, our services and our marketplace differentiation.

AAPS 2022 Lunch & Learn Seminar with Charles River

Join experts from Charles River & Quotient Sciences for a complimentary lunch seminar during AAPS on October 18.

Streamlining the Delivery of 14C Human ADME Data: An ADME Q&A Roundtable

On December 6, 2022, join Quotient Sciences and The Netherlands Organization for Applied Scientific Research (TNO) for an interactive, hour-long live Q&A webinar focused on streamlining human ADME studies.

Integrated Development Strategies Lunch Seminar- Alnwick, UK

Join senior leaders from Charles River and Quotient Sciences as they discuss how their collaboration helps customers by bringing expert knowledge, removing obstacles from the critical path, reducing development risks, and shortening the pathway to clinical development and beyond. Through case studies they will demonstrate how an integrated program provides customers with the full set of deliverables required to be “clinic ready”, and how this seamless transition between providers can improve the chances of clinical and commercial success.

What we do

Global Clinical Trial Supplies

Clinical Trial Manufacturing

Modified-Release Formulation Strategies

With over 30 years of formulation expertise and over 100 MR programs developed, the team at Quotient Sciences possess the experience, capabilities, and technologies needed to create a successful MR formulation.

Get in touch
Humanity can’t afford to wait, so neither can we.
Let’s talk.